TOLLWUTVIRUSÄHNLICHE GLYCOPROTEINPARTIKEL

European patent · EP2635257 · In force

Register entry

Publication number
EP2635257
Application number
EP11838942
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 7, 2011
Published
Sep 11, 2013
Granted
Jul 5, 2017
Protection ends at the latest
Nov 6, 2031
Next annual fee due
Nov 30, 2026
IPC classes
A61K 9/127 (2006.01)
A61K 39/205 (2006.01)
A61K 39/12 (2006.01)
C07K 14/005 (2006.01)
A61K 39/00 (2006.01)
Priority
US 410767 P 05.11.2010
PCT application
PCT/US2011/059602 07.11.2011
PCT publication
WO2012/061815 10.05.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 6, 2022

    Change

    Published in Swissreg on 06.12.2022

  5. Aug 24, 2017

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 24.08.2017

  6. Jul 5, 2017

    Granted

    Published in Swissreg on 05.07.2017

Parties

Holder

Novavax, Inc.

9920 Belward Campus Drive, Rockville, MD 20850, US

Agent

MICHELI & CIE SA

122, Rue de Genève Case postale 61, 1226 Thônex

Inventor

SMITH, Gale

Rockville, Maryland 20850, US

LIU, Ye

Rockville, Maryland 20850, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.